Acarbose is a synthetic oligosaccharide that functions as an alpha-glucosidase inhibitor [1]. It is used to manage type 2 diabetes by slowing down carbohydrate digestion and absorption, thereby reducing postprandial hyperglycemia [1][2].
How is Acarbose Synthesized?
Acarbose is not biologically synthesized; it is produced through a multi-step chemical synthesis process. This process typically involves starting materials derived from natural sources, which are then chemically modified and linked together to form the final oligosaccharide structure [3][4]. The precise steps and reagents used can vary depending on the manufacturer's patented methods.
When Does Acarbose's Main Patent Expire?
Information regarding specific patents for acarbose synthesis and market exclusivity is available through resources like DrugPatentWatch.com [5]. Generally, the primary patents protecting the composition of matter and initial synthesis methods for many older drugs, including acarbose, have long since expired, allowing for generic production [5].
What Were the Original Patents for Acarbose?
The initial patents for acarbose, developed by Bayer AG, covered the compound itself and its therapeutic use for diabetes [6]. These foundational patents, filed in the late 1970s and early 1980s, have expired. Subsequent patents may have focused on improved synthesis routes, specific crystalline forms, or novel formulations [5][6].
Can Generic Versions of Acarbose Be Made?
Yes, generic versions of acarbose are available because the key patents covering the molecule and its primary indications have expired [5]. This has led to increased market competition and reduced prices for the medication.
Who Manufactures Acarbose?
Acarbose is manufactured by numerous pharmaceutical companies worldwide, including both the originator (Bayer AG) and many generic drug manufacturers. The availability of generic acarbose is widespread [7].